These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6339367)

  • 21. [Diseases associated with the HLA histocompatibility system].
    Mejías E
    Bol Asoc Med P R; 1981 Apr; 73(4):203-7. PubMed ID: 6975638
    [No Abstract]   [Full Text] [Related]  

  • 22. The HLA system and its relation to disease.
    McDevitt HO
    Hosp Pract (Off Ed); 1985 Jul; 20(7):57-72. PubMed ID: 3159741
    [No Abstract]   [Full Text] [Related]  

  • 23. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products.
    Puri NK; de Kretser T; Brandon MR
    Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactivity of HTLV-transformed human T-cell lines to MHC class II antigens.
    Suciu-Foca N; Rubinstein P; Popovic M; Gallo RC; King DW
    Nature; 1984 Nov 15-21; 312(5991):275-7. PubMed ID: 6095090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance.
    Christadoss P; Shenoy M; Oshima M; Atassi MZ
    Adv Exp Med Biol; 1994; 347():65-75. PubMed ID: 7976734
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapy of autoimmune disease with monoclonal antibodies to class II gene products of the major histocompatibility complex.
    Steinman L
    Prog Allergy; 1988; 45():161-7. PubMed ID: 3217425
    [No Abstract]   [Full Text] [Related]  

  • 27. [Histocompatibility antigens and autoimmune diseases].
    Pérez González J; Sarriá A; Legido A; Ventura P; Larrad L
    An Esp Pediatr; 1985 Aug; 23(2):112-6. PubMed ID: 3864387
    [No Abstract]   [Full Text] [Related]  

  • 28. A possible split of antigen DQw1 identified by antiserum T3516.
    Satake M; Matsuki K; Yabe T; Suzuki M; Juji T
    Tissue Antigens; 1986 Mar; 27(3):155-62. PubMed ID: 3520951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insignificant immune phagocytosis inhibition and cytotoxicity by the murine monoclonal HLA-DP antibody B7/21 tested on human monocytes and macrophages.
    Neppert J
    Scand J Immunol; 1986 Sep; 24(3):321-6. PubMed ID: 3489287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes.
    Ridgway WM; Fathman CG
    Clin Immunol Immunopathol; 1998 Jan; 86(1):3-10. PubMed ID: 9434791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte surface antigens.
    Stastny P; Nunez G
    Prog Clin Biol Res; 1984; 149():189-203. PubMed ID: 6234600
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
    Masuyama J; Minato N; Kano S
    J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A functional and biochemical analysis of bovine class II MHC antigens using monoclonal antibodies.
    Emery DL; Puri NK; Dufty JH; Gorrell MD; Brandon MR
    Vet Immunol Immunopathol; 1987 Nov; 16(3-4):215-34. PubMed ID: 3324460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of human T lymphocytes to phytohemagglutinin (PHA) after sequential depletion of monocytes, HLA-DR+, Leu11a+, and Leu7+ cells.
    Ulmer AJ; Scholz W; Ernst M; Flad HD
    Immunobiology; 1985 Dec; 170(5):419-33. PubMed ID: 2936677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genes of the immune response: disease associations.
    Cox DW
    Genome; 1989; 31(2):1085-6. PubMed ID: 2632336
    [No Abstract]   [Full Text] [Related]  

  • 36. Autoimmunity in non-human primates: the role of major histocompatibility complex and T cells, and implications for therapy.
    Jonker M; Bakker K; Slierendregt B; Hart B; Bontrop R
    Hum Immunol; 1991 Sep; 32(1):31-40. PubMed ID: 1774194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of major histocompatibility complex class II antigen on target cells in autoimmune endocrine diseases.
    Hanafusa T
    Nihon Naibunpi Gakkai Zasshi; 1988 Dec; 64(12):1228-32. PubMed ID: 2977760
    [No Abstract]   [Full Text] [Related]  

  • 38. Defective expression of mononuclear cell membrane HLA antigens associated with combined immunodeficiency: impaired cellular interactions.
    Zegers BJ; Heijnen CJ; Roord JJ; Kuis W; Schuurman RK; Stoop JW; Ballieux RE
    Birth Defects Orig Artic Ser; 1983; 19(3):93-6. PubMed ID: 6228275
    [No Abstract]   [Full Text] [Related]  

  • 39. Susceptibility to autoimmune disease: a multigenic viewpoint.
    Petrányi GG
    Immunol Today; 1992 Aug; 13(8):A19-20. PubMed ID: 1510804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA genes and disease susceptibility.
    Rodey GE
    Prog Clin Biol Res; 1984; 149():235-53. PubMed ID: 6429665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.